The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
Open Access
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (13), 11123-11129
- https://doi.org/10.1074/jbc.m206169200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pharmacological characterization of antagonists of the C5a receptorBritish Journal of Pharmacology, 1999
- Acylation stimulating protein (ASP), an adipocyte autocrine: new directionsSeminars in Cell & Developmental Biology, 1999
- Inhibition of Anaphylatoxin C3a– and C5a– But Not Nerve Stimulation– or Noradrenaline–Dependent Increase in Glucose Output and Reduction of Flow in Kupffer Cell–Depleted Perfused Rat LiversHepatology, 1996
- Differentiation‐induced production of ASP in human adipocytesEuropean Journal of Clinical Investigation, 1995
- Mutation of Glutamate 199 of the Human C5a Receptor Defines a Binding Site for Ligand Distinct from the Receptor N TerminusPublished by Elsevier ,1995
- The Human Chemoattractant Complement C5a Receptor Inhibits Cyclic AMP Accumulation Through Gi and Gz ProteinsBiochemical and Biophysical Research Communications, 1995
- Selective coupling of the human anaphylatoxin C5a receptor and α16 in human kidney 293 cellsFEBS Letters, 1993
- Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.Journal of Clinical Investigation, 1990
- Binding specificity and presynaptic action of anaphylatoxin C5a in rat brainBrain, Behavior, and Immunity, 1989
- Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamusJournal of Neuroimmunology, 1983